AUNA (AUNA) Q1 2026: Free Cash Flow Surges 2.6x as Platform Mix Shifts to High Complexity
Free cash flow multiplied in Q1 as AUNA’s regional healthcare platform accelerated its shift toward higher complexity, risk-sharing contracts, and B2B membership growth across Mexico, Peru, and Colombia. Margin and EBITDA headwinds from Peru’s revenue adjustments and payroll inflation were offset by robust volume gains and improved payer mix, reinforcing management’s confidence in full-year guidance. Execution focus remains on scaling oncology and risk-sharing in Mexico and Colombia, while Peru’s normalization and ongoing cost discipline are set to drive a stronger second half.
Summary
- Cash Generation Outpaces Margin Compression: Strong working capital and supplier financing initiatives drove free cash flow higher despite margin headwinds.
- Strategic Mix Shift Accelerates: High complexity volumes and risk-sharing contracts expanded, supporting future margin recovery and revenue predictability.
- Second-Half Inflection in Focus: Management targets margin and EBITDA acceleration as new contracts and scale efficiencies take hold.
Business Overview
AUNA operates a vertically integrated healthcare platform in Latin America, generating revenue from hospital services, insurance plans, and risk-sharing contracts across Mexico, Peru, and Colombia. Its business model combines fee-for-service, B2B insurance (notably through OncoSalud, its oncology plan business), and direct government and commercial payer relationships. The company’s three main segments—Mexico, Peru, and Colombia—each contribute distinct revenue streams and growth levers, with a focus on high-complexity care, payer mix optimization, and expanding plan membership.
Performance Analysis
AUNA delivered 10% FX-neutral revenue growth in Q1, with all segments contributing. Mexico rebounded on the back of higher service volumes—especially in surgeries and oncology—while Peru maintained momentum with expanding plan membership and high-complexity service uptake. Colombia accelerated its risk-sharing model, reducing exposure to government-intervened payers and increasing revenue predictability.
Despite this top-line momentum, adjusted EBITDA declined 5% FXN due to two extraordinary items: revenue reconciliation penalties in Peru and payroll inflation in Mexico and Colombia. Margin contraction was most pronounced in Peru, driven by delayed rebate recognition and higher doctor compensation. However, free cash flow surged 2.6 times YoY, reflecting disciplined working capital management and supplier financing initiatives. Leverage ticked up to 3.7x, but management attributed this to non-cash FX effects and reaffirmed its medium-term target of 3x.
- Mexico Margin Recovery: EBITDA increased 19% QoQ, with margin up 3.5 points on improved payer contracts and high-complexity mix.
- Peru Revenue Adjustments: Penalties and delayed rebates weighed on profitability, but plan membership continues to grow, especially in B2B.
- Colombia Risk-Sharing Expansion: Risk-sharing contracts now represent 21% of segment revenue, supporting cash flow stability despite initial margin dilution.
Management’s narrative is clear: the core platform is scaling, underlying volume growth is robust, and margin headwinds are viewed as temporary, with a stronger second half expected as operational leverage improves.
Executive Commentary
"We have stabilized and restored growth in AUNA Mexico's hospital platform. We have strengthened AUNA Colombia's hospital platform by expanding our unique risk-sharing businesses and deepening our relationships with the country's largest and best capitalized payers."
Suso Zamora, Executive Chairman and President
"Our free cash flow increased 2.6 times versus the first quarter of 2025 to 152 million soles, primarily on a 45% increase in pre-tax operating cash flow shown at the left of the bridge. This reflects our strong growth coupled with higher cash conversion resulting from solid working capital management as well as supplier financing initiatives that we've undertaken."
Giselle Remy, Chief Financial Officer and Executive Vice President
Strategic Positioning
1. High Complexity and Oncology Scale
AUNA’s push into high complexity services—particularly oncology— is central to its margin recovery and growth narrative. In Mexico, oncology and surgeries grew double digits, with radiotherapy investments expected to further boost margins. Management emphasized that oncology, while initially lower margin, will benefit from scale and fixed-cost dilution, shifting the profit profile upward over time.
2. Risk-Sharing Model in Colombia
Risk-sharing agreements—where AUNA shares financial risk with payers— now comprise 21% of Colombia revenue, up from 15% last year. This model reduces exposure to politically sensitive, government-intervened payers, and enhances cash predictability. While initial margin impact is negative, management expects margin normalization as volume and cost optimization mature.
3. B2B and Plan Membership Growth
OncoSalud’s B2B growth in Peru and expanded group policies, such as the 20,000-member judiciary contract, illustrate AUNA’s ability to win large institutional clients. This provides volume stability and pricing power, especially as commercial initiatives continue to drive penetration in underpenetrated markets.
4. Working Capital and Cash Conversion
Supplier financing and working capital initiatives across all geographies have materially improved cash flow, with accounts payable days extended and factoring lines increased. This supports both growth investment and deleveraging, even as leverage temporarily rises due to FX effects.
5. Platform Simplification and Predictability
Management repeatedly emphasized a commitment to simplifying the business model and reducing surprises for investors. Initiatives to shorten billing cycles and improve revenue cycle management are expected to reduce future penalty risk and improve margin visibility.
Key Considerations
This quarter’s results highlight both the complexity and the opportunity within AUNA’s multi-country healthcare platform. Investors should weigh the following:
- Margin Recovery Hinges on Scale: Oncology and risk-sharing require volume to unlock operating leverage, with margin expansion likely back-end loaded.
- Cash Flow Strength Underpins Flexibility: Free cash flow outperformance gives AUNA room to invest and manage leverage despite temporary margin pressure.
- Revenue Quality Over Quantity: Shifting away from government-intervened payers in Colombia and focusing on high-value B2B contracts in Peru improves revenue predictability and risk profile.
- FX and Regulatory Sensitivity: Currency moves and evolving healthcare policy, particularly in Colombia and Mexico, remain material swing factors for both reported results and strategic direction.
Risks
Short-term margin compression, especially in Peru and Colombia, could persist if revenue adjustments or wage inflation outpace volume gains. Political and regulatory risk in Colombia remains a watchpoint, though management believes the worst is behind. FX volatility continues to impact leverage and reported earnings, though hedging strategies have been reset to mitigate future swings. Execution risk around scaling new service lines and managing payer relationships is elevated in a multi-market context.
Forward Outlook
For Q2 2026, AUNA anticipates:
- Continued revenue growth across all segments, with full-quarter impact from new Mexico payer contracts.
- Margin improvement as oncology and high-complexity volumes scale and Peru’s revenue adjustments normalize.
For full-year 2026, management reaffirmed guidance:
- Revenue and adjusted EBITDA growth, with a stronger second half expected due to seasonality and contract ramp-up.
Management highlighted:
- Stronger cash flow generation and ongoing deleveraging as priorities.
- Operational improvements in billing, working capital, and supplier financing to further support margin and cash conversion.
Takeaways
- Cash Flow Outperformance: Working capital and supplier financing initiatives are driving robust free cash flow, supporting growth and capital discipline.
- Strategic Mix Shift: Expansion in high complexity and risk-sharing contracts is improving revenue visibility and setting up margin recovery, even as near-term profitability is pressured by one-off items.
- Second Half Acceleration: Investors should monitor the pace of margin normalization and volume growth in Mexico and Colombia as key indicators of guidance achievability.
Conclusion
AUNA’s Q1 2026 results underscore a platform in transition— with cash flow strength, commercial momentum, and a clear strategy to scale high-value segments. Margin headwinds are real but appear transitory, with management’s focus on operational discipline and mix optimization setting the stage for a stronger second half and sustainable growth trajectory.
Industry Read-Through
AUNA’s results highlight several key industry trends: the growing importance of risk-sharing contracts in emerging market healthcare, the operational leverage available from scaling high-complexity services, and the need for disciplined working capital management in capital-intensive, multi-payer environments. Other regional healthcare operators may face similar margin and FX headwinds, but those able to shift payer mix, deepen B2B relationships, and invest in billing and cash conversion systems will be best positioned to weather volatility and capture growth. The trend toward public-private partnerships in universal healthcare initiatives, especially in Mexico, signals a broader opportunity for integrated platforms with scale and operational sophistication.